1.Sporadic Nonfamilial Hypophosphatemic Osteomalacia
Young Kee SHONG ; Joong Yeol PARK ; Ghi Su KIM ; You Sook CHO ; Goo Yeong CHO ; Sang Wook KIM ; Jung Sik PARK ; Ki Up LEE
Journal of Korean Society of Endocrinology 1994;9(1):25-31
Chronic hypophosphatemia caused by decreased intestinal absorption or increased renal clearance, may lead to rickets or osteomalacia independently of other predisposing abnormalities. The conditions commonly associated with increased renal clearance of phosphate are X-linked hypophosphatemic rickets, tumor associated rickets/osteomalacia, RTA and Fanconi syndrome. Recently we experienced 3 men with adult-onset, histologically proven osteomalacia associated with increased renal clearance of phosphate. None of them had a family history of bone disease, tumors or other tubular defects. All of these had remarkable biochemical and clinical improvement with medical treatment such as 1, 25-dihydroxyvitamin D and phosphate supplementation. Although we did not find tumors yet, we could not rule out the possibility of tumor-associated osteomalcia since it often takes several years to make a diagnosis because of small size, benign nature and unusual location of tumors. Thus, careful long-term follow up for tumor occurrence will be maintained in these patients with sporadic nonfamilial hypophosphatemic osteomalacia.
Bone Diseases
;
Diagnosis
;
Familial Hypophosphatemic Rickets
;
Fanconi Syndrome
;
Follow-Up Studies
;
Humans
;
Hypophosphatemia
;
Intestinal Absorption
;
Male
;
Osteomalacia
;
Rickets
2.Clinical Study of Hypophosphatemic Rickets.
Chang Jin LEE ; Hee Yeon CHO ; Ju Hyung KANG ; Choong Ho SHIN ; Il Soo HA ; Hae Il CHEONG ; Sei Won YANG ; Yong CHOI
Journal of the Korean Society of Pediatric Nephrology 2004;8(2):195-204
PURPOSE: Hypophosphatemic rickets is a hereditary disease, characterized by hypophosphatemia due to renal phosphate wasting, impaired renal production of 1,25-dihydroxyvitamin D3, rachitic bone deformities and impaired growth. The purpose of this study is to provide clinical profiles of patients with hypophosphatemic rickets in our hospital. METHODS: Between July 1983 and February 2004, 56 patients were diagnosed as having hypophosphatemic rickets. The medical records of these patients were reviewed retrospectively. Clinical manifestations, family histories, laboratory data, treatment outcomes were described. RESULTS: Fifty six patients were enrolled in this study. The average age at symptom onset and diagnosis were 20 months and 5 years respectively. Fourteen patients had family histories. The main clinical manifestations were bow legs and short stature. There was a significant negative correlation between the ages and the height z-scores at the time of diagnosis(r=-0.47, P=0.005). Initial laboratory data showed normocalcemia, hypophosphatemia, elevated serum alkaline phosphatase, decreased tubular reabsorption of phosphate and a normal range of 1,25-dihydroxyvitamin D3. Radiographic examinations of bone revealed fraying, widening and cupping of the metaphyseal ends. Treatment consisted of Joulie solution and vitamin D metabolites, and resulted in improved biochemical and radiographic findings. However, height z-scores remained essentially unchanged(P=0.224). Complications of treatment were frequently observed, including hyperparathyroidism, nephrocalcinosis, and hypercalciuria. Sixteen patients had corrective osteotomy and 4 of them underwent leg lengthening together. CONCLUSION: There was a gap of several years between the onset of symptoms and the diagnosis. Early treatment seems to be essential to growth. For the earlier treatment, the offsprings of affected parents should be followed up closely.
Alkaline Phosphatase
;
Calcitriol
;
Congenital Abnormalities
;
Diagnosis
;
Familial Hypophosphatemic Rickets
;
Genetic Diseases, Inborn
;
Genu Varum
;
Humans
;
Hypercalciuria
;
Hyperparathyroidism
;
Hypophosphatemia
;
Hypophosphatemia, Familial
;
Leg
;
Medical Records
;
Nephrocalcinosis
;
Osteotomy
;
Parents
;
Reference Values
;
Retrospective Studies
;
Rickets, Hypophosphatemic*
;
Vitamin D
3.Dental management of patients with X-linked hypophosphatemia.
Bin Na LEE ; Hye Yoon JUNG ; Hoon Sang CHANG ; Yun Chan HWANG ; Won Mann OH
Restorative Dentistry & Endodontics 2017;42(2):146-151
X-linked hypophosphatemia (XLH) is a hereditary metabolic disease caused by the loss of phosphate through the renal tubules into the urine, and an associated decrease in serum calcium and potassium phosphate. Its dental features include spontaneous dental abscesses that occur in the absence of trauma or dental caries. The aim of this case report was to describe the dental problems of XLH patients and to evaluate limitations in their treatment. A 14 year old male and a 38 year old female with XLH were referred to the Department of Conservative Dentistry for endodontic treatment. The dental findings were periapical abscesses without obvious trauma or caries. Conservative endodontic treatment was performed in teeth with pulp necrosis and abscess. In case 1, the treated teeth showed improvements in bone healing, without clinical symptoms. However, in case 2, the implants and the treated tooth showed hypermobility, and the final restoration was therefore postponed. Early diagnosis, periodic examinations, and communication with the patient's pediatrician are important in the dental management of patients with XLH.
Abscess
;
Calcium
;
Dental Caries
;
Dental Pulp Necrosis
;
Dentistry
;
Early Diagnosis
;
Familial Hypophosphatemic Rickets*
;
Female
;
Humans
;
Hypophosphatemia
;
Male
;
Metabolic Diseases
;
Periapical Abscess
;
Potassium
;
Tooth
4.Skeletal mineralization: mechanisms and diseases
Annals of Pediatric Endocrinology & Metabolism 2019;24(4):213-219
Skeletal mineralization is initiated in matrix vesicles (MVs), the small extracellular vesicles derived from osteoblasts and chondrocytes. Calcium and inorganic phosphate (Pi) taken up by MVs form hydroxyapatite crystals, which propagate on collagen fibrils to mineralize the extracellular matrix. Insufficient calcium or phosphate impairs skeletal mineralization. Because active vitamin D is necessary for intestinal calcium absorption, vitamin D deficiency is a significant cause of rickets/osteomalacia. Chronic hypophosphatemia also results in rickets/osteomalacia. Excessive action of fibroblast growth factor 23 (FGF23), a key regulator of Pi metabolism, leads to renal Pi wasting and impairs vitamin D activation. X-linked hypophosphatemic rickets (XLH) is the most common form of hereditary FGF23-related hypophosphatemia, and enhanced FGF receptor (FGFR) signaling in osteocytes may be involved in the pathogenesis of this disease. Increased extracellular Pi triggers signal transduction via FGFR to regulate gene expression, implying a close relationship between Pi metabolism and FGFR. An anti-FGF23 antibody, burosumab, has recently been developed as a new treatment for XLH. In addition to various forms of rickets/osteomalacia, hypophosphatasia (HPP) is characterized by impaired skeletal mineralization. HPP is caused by inactivating mutations in tissue-nonspecific alkaline phosphatase, an enzyme rich in MVs. The recent development of enzyme replacement therapy using bone-targeting recombinant alkaline phosphatase has improved the prognosis, motor function, and quality of life in patients with HPP. This links impaired skeletal mineralization with various conditions, and unraveling its pathogenesis will lead to more precise diagnoses and effective treatments.
Absorption
;
Alkaline Phosphatase
;
Calcium
;
Chondrocytes
;
Collagen
;
Diagnosis
;
Durapatite
;
Enzyme Replacement Therapy
;
Extracellular Matrix
;
Extracellular Vesicles
;
Familial Hypophosphatemic Rickets
;
Fibroblast Growth Factors
;
Gene Expression
;
Humans
;
Hypophosphatasia
;
Hypophosphatemia
;
Metabolism
;
Miners
;
Osteoblasts
;
Osteocytes
;
Prognosis
;
Quality of Life
;
Receptors, Fibroblast Growth Factor
;
Rickets
;
Signal Transduction
;
Vitamin D
;
Vitamin D Deficiency
5.Value of serum fibroblast growth factor 23 in diagnosis of hypophosphatemic rickets in children.
Sha-Sha DONG ; Ruo-Chen CHE ; Bi-Xia ZHENG ; Ai-Hua ZHANG ; Chun-Li WANG ; Mi BAI ; Ying CHEN
Chinese Journal of Contemporary Pediatrics 2023;25(7):705-710
OBJECTIVES:
To study the value of serum fibroblast growth factor 23 (FGF23) in the diagnosis of hypophosphatemic rickets in children.
METHODS:
A total of 28 children who were diagnosed with hypophosphatemic rickets in Children's Hospital of Nanjing Medical University from January 2016 to June 2021 were included as the rickets group. Forty healthy children, matched for sex and age, who attended the Department of Child Healthcare of the hospital were included as the healthy control group. The serum level of FGF23 was compared between the two groups, and the correlations of the serum FGF23 level with clinical characteristics and laboratory test results were analyzed. The value of serum FGF23 in the diagnosis of hypophosphatemic rickets was assessed.
RESULTS:
The rickets group had a significantly higher serum level of FGF23 than the healthy control group (P<0.05). In the rickets group, the serum FGF23 level was positively correlated with the serum alkaline phosphatase level (rs=0.38, P<0.05) and was negatively correlated with maximum renal tubular phosphorus uptake/glomerular filtration rate (rs=-0.64, P<0.05), while it was not correlated with age, height Z-score, sex, and parathyroid hormone (P>0.05). Serum FGF23 had a sensitivity of 0.821, a specificity of 0.925, an optimal cut-off value of 55.77 pg/mL, and an area under the curve of 0.874 in the diagnosis of hypophosphatemic rickets (P<0.05).
CONCLUSIONS
Serum FGF23 is of valuable in the diagnosis of hypophosphatemic rickets in children, which providing a theoretical basis for early diagnosis of this disease in clinical practice.
Child
;
Humans
;
Fibroblast Growth Factor-23
;
Fibroblast Growth Factors
;
Familial Hypophosphatemic Rickets/diagnosis*
;
Rickets, Hypophosphatemic/diagnosis*
6.A Case of Osteosarcoma induced Oncogenic Osteomalacia Detected by MRI.
Sung Kil LIM ; Young Duk SONG ; Hyun Chul LEE ; Kap Bum HUH ; Ki Hyun PARK ; Kyung Rae KIM ; Soon Won HONG ; Jae Hyun NAM ; Jong In YOOK ; Byung Joo CHOI ; Mi Kyung KIM ; Kyu Ho SHIN
Journal of Korean Society of Endocrinology 1999;14(2):401-409
Oncogenic osteomalacia is a syndrome characterized by phosphaturia, hypophosphatemia, decreased 1,25-dihydroxyvitamin D level and specific signs and symptoms of osteomalacia. It is associated with the presence of neoplasm originated from mesenchyme. Until now, less than 100 cases of oncogenic osteomalacia have been reported. The pathophysiology of oncogenic osteomalacia has not been fully understood, but it has been suggested that a certain substance released by tumor may inhibit not only la-hydroxylase activity and reduce 1,25-dihydroxyvitamin D level in part, but directly inhibit reabsorption of phosphate. And then, reduced phosphaturia, hypophosphatemia and eventually osteomalacia develop. We report a case of osteosarcoma induced oncogenic osteomalacia detected by MRI in 59 year old woman.
Female
;
Humans
;
Hypophosphatemia
;
Hypophosphatemia, Familial
;
Magnetic Resonance Imaging*
;
Mesoderm
;
Middle Aged
;
Osteomalacia*
;
Osteosarcoma*
7.Severe hypophosphatemia in hospitalized patients.
Sin Ju KANG ; Jee Yoon KIM ; Hyun Jin PARK ; Duk Hee HAN ; Byung Hee YU ; Sung Soo MOON
Korean Journal of Nephrology 1991;10(3):330-335
No abstract available.
Humans
;
Hypophosphatemia*
8.Case report of tumour-induced osteomalacia with parotid gland tumour as a focus.
Jyotsna Oak ; Girish Parmar ; Satish Sharma ; Bijal Kulkarni ; Laxmi Patil
Journal of the ASEAN Federation of Endocrine Societies 2016;31(2):171-177
Tumour-induced osteomalacia (TIO) is a rare paraneoplastic syndrome, which is characterized by overproduction of FGF23 as a phosphaturic agent leading to chronic phosphaturia and hypophosphatemia, associated with inappropriately normal or low levels of vitamin D. We describe a rare case of a 57-year-old Indian female who presented with bone pains, muscle pains and lower limb weakness. On examination she was found to have hypophosphatemia. Our work up led to the identification of a FGF23 secreting parotid tumour. The tumour responsible for symptoms was a pleomorphic adenoma of the parotid gland. Its complete resection resulted in normalisation of patient's symptoms. Laboratory parameters and microsopic examination further revealed a mesenchymal tumour of mixed connective tissue type.
Human ; Female ; Middle Aged ; Adenoma, Pleomorphic ; Connective Tissue ; Hypophosphatemia ; Hypophosphatemia, Familial ; Lower Extremity ; Neoplasms, Connective Tissue ; Paraneoplastic Syndromes ; Parotid Gland ; Parotid Neoplasms ; Vitamin D ; Hypophosphatemia
9.A novel de novo mosaic mutation in PHEX in a Korean patient with hypophosphatemic rickets.
Misun YANG ; Jinsup KIM ; Aram YANG ; Jahyun JANG ; Tae Yeon JEON ; Sung Yoon CHO ; Dong Kyu JIN
Annals of Pediatric Endocrinology & Metabolism 2018;23(4):229-234
X-linked hypophosphatemic rickets is caused by loss-of-function mutations in PHEX, which encodes a phosphate-regulating endopeptidase homolog. We report a 26-year-old man with X-linked hypophosphatemic rickets who showed decreased serum phosphate accompanied by bilateral genu valgum and short stature. He had received medical treatment with vitamin D (alfacalcidol) and phosphate from the age of 3 to 20 years. He underwent surgery due to valgus deformity at the age of 14 and 15. Targeted gene panel sequencing for Mendelian genes identified a nonsense mutation in PHEX (c.589C>T; p.Gln197Ter) and a mosaic pattern where only 38% of sequence reads showed the variant allele. This mutation was not found in his mother, who had a normal phenotype. This is a case of a sporadic nonsense mutation in PHEX and up to date, this is the first case of a mosaic mutation in PHEX in Korea.
Adult
;
Alleles
;
Codon, Nonsense
;
Congenital Abnormalities
;
Familial Hypophosphatemic Rickets
;
Genu Valgum
;
Humans
;
Korea
;
Mothers
;
Phenotype
;
Rickets, Hypophosphatemic*
;
Vitamin D
10.Three Cases of Osteomalacia with Fractures Induced by Adefovir in Chronic Hepatitis B
Ah Reum KIM ; Yong Jun CHOI ; Yoon Sok CHUNG
Journal of Korean Society of Osteoporosis 2015;13(2):109-116
Adefovir dipivoxil is used antiviral agent in the treatment of chronic hepatitis B virus infection. This drug is recommended for patients infected with lamivudine-refractory hepatitis B. Many studies of low-dose adefovir have shown little evidence of renal tubular dysfunction. However, hypophosphatemic osteomalacia has recently been reported in patients treated with adefovir. We report three cases of low dose adefovir-induced hypophosphatemic osteomalacia with fractures. All three patients had been receiving adefovir due to lamivudine-refractory hepatitis B, presented multiple bone pain. The laboratory tests revealed hypophosphatemia and phosphaturia. Bone scintigraphy showed increased uptake in multiple lesions. They were diagnosed as adefovir induced hypophophatemic osteomalacia. Changing the antiviral agent and administration of calcitriol and phosphates improved hypophosphatemia and clinical symptoms. Patients with hepatitis B virus treated with adefovir should be monitored with the serum phosphate levels and presenting symptoms of diffuse bone pain, clinicians need to suspect this infrequent complication.
Calcitriol
;
Hepatitis B
;
Hepatitis B virus
;
Hepatitis B, Chronic
;
Hepatitis, Chronic
;
Humans
;
Hypophosphatemia
;
Hypophosphatemia, Familial
;
Osteomalacia
;
Phosphates
;
Radionuclide Imaging